Usefulness of Helicobacter pylori Eradication Therapy with a PPI (or Potassium-competitive Acid Blocker), Metronidazole, and Sitafloxacin in Patients with Penicillin Allergy

被引：0
|
作者：
Tanaka, Akifumi [1 ]
Tokunaga, Kengo [1 ]
Takahashi, Shin'ichi [2 ]
Mori, Hideaki [3 ]
Hisamatsu, Tadakazu [4 ]
机构：
[1] Kyorin Univ, Sch Med, Dept Internal Med 3, Mitaka, Tokyo, Japan
[2] Kyorin Univ, Sch Med, Kosei Hosp, Dept Internal Med 3, Tokyo, Tokyo, Japan
[3] Kyorin Univ, Sch Med, Tokyo, Tokyo, Japan
[4] Kyorin Univ, Sch Med, Dept Internal Med 3, Tokyo, Tokyo, Japan
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2016年 / 111卷
关键词：
D O I：
10.14309/00000434-201610001-02543
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2543
引用
收藏
页码：S1289 / S1289
页数：1
相关论文
共 50 条
  • [1] Helicobacter pylori Eradication Therapy With a Potassium-Competitive Acid Blocker, Metronidazole, and Sitafloxacin in Patients With Penicillin Allergy
    Tanaka, Akifumi
    Tokunaga, Kengo
    Takahashi, Shin'ichi
    Mori, Hideaki
    Hisamatsu, Tadakazu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S680 - S680
  • [2] Eradication of Helicobacter pylori by a potassium-competitive acid blocker alone?
    Waldum, Helge
    Fossmark, Reidar
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2025, 60 (01) : 10 - 12
  • [3] Eradication of Helicobacter pylori with Sitafloxacin Plus Metronidazole Based Triple Therapy for Penicillin Allergy Patients
    Mori, Hideki
    Suzuki, Hidekazu
    Matsuzaki, Juntaro
    Masaoka, Tatsuhiro
    Kanai, Takanori
    DIGESTION, 2017, 95 (01) : 93 - 93
  • [4] USEFULNESS OF HELICOBACTOR PYLORI ERADICATION THERAPY INCLUDING SITAFLOXACIN FOR PATIENTS WITH PENICILLIN ALLERGY
    Sahara, S.
    Sugimoto, M.
    Uotani, T.
    Ichikawa, H.
    Yamada, T.
    Osawa, S.
    Sugimoto, K.
    Furuta, T.
    HELICOBACTER, 2013, 18 : 133 - 133
  • [5] Efficacy of Sitafloxacin-Based Triple Therapy for Eradication-Refractory Helicobacter Pylori and Salvage Therapy With the New Potassium-Competitive Acid Blocker Vonoprazan
    Okimoto, Kenichiro
    Arai, Makoto
    Kasamatsu, Shingo
    Ishigami, Hideaki
    Saito, Keiko
    Maruoka, Daisuke
    Matsumura, Tomoaki
    Nakagawa, Tomoo
    Katsuno, Tatsuro
    Yokosuka, Osamu
    GASTROENTEROLOGY, 2016, 150 (04) : S447 - S447
  • [6] The cost effectiveness of vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter pylori eradication therapy
    Hosokawa, Takanori
    Kaminishi, Michio
    Nouchi, Toshihiko
    Takeda, Yuichi
    Kojima, Shigeru
    Ono, Keichi
    Uraushihara, Koji
    Yamadi, Osamu
    Suzuki, Shoko
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 62 - 62
  • [7] EFFICACY AND SAFETY OF VONOPRAZAN, SITAFLOXACIN AND METRONIDAZOLE CONTAINING REGIMEN FOR HELICOBACTER PYLORI ERADICATION IN PATIENTS WITH PENICILLIN ALLERGY
    Masaoka, Tatsuhiro
    Mori, Hideki
    Suzuki, Hidekazu
    Matsuzaki, Juntaro
    Okazawa, Akira
    Yoshioka, Masahiro
    Inokuchi, Kazumi
    Kanai, Takanori
    GASTROENTEROLOGY, 2020, 158 (06) : S574 - S574
  • [8] Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children
    Chika Kusano
    Takuji Gotoda
    Sho Suzuki
    Hisatomo Ikehara
    Mitsuhiko Moriyama
    Journal of Gastroenterology, 2018, 53 : 718 - 724
  • [9] Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children
    Kusano, Chika
    Gotoda, Takuji
    Suzuki, Sho
    Ikehara, Hisatomo
    Moriyama, Mitsuhiko
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (06) : 718 - 724
  • [10] Potassium-Competitive Acid Blocker Antisecretory Therapy Improves H. pylori Eradication
    Matsumoto, Hiroshi
    Kamada, Tomoari
    Oosawa, Motoyasu
    Katsumata, Ryo
    Fujita, Minoru
    Nakato, Rui
    Murao, Takahisa
    Ishii, Manabu
    Kusunoki, Hiroaki
    Haruma, Ken
    Shiotani, Akiko
    GASTROENTEROLOGY, 2016, 150 (04) : S878 - S878
12345